Guardant Health
Corporate Development Director, Merger & Acquisition (Hybrid, 3-Days in Palo Alt
Guardant Health, Palo Alto, California, United States, 94306
Corporate Development Director, Merger & Acquisition (Hybrid, 3-Days in Palo Alto, CA Office)
Full-timeGuardant Health is the leading precision oncology company with a dedication to conquering cancer globally. The Company was the first to develop proprietary genomics tests utilizing vast data sets and advanced analytics to find and characterize the basis of cancer in each patient individually. The Company operates through two unique platforms: Oncology and Screening.About the RoleThe Corporate Development Director is responsible for supporting the Corporate Development function for Guardant Health. The role will be integral in all group functional capacities and requires a self-starter familiar with the capital markets, strategy, valuation, and financial analysis. An ability to understand the basics of genomics is helpful to succeed. The candidate will help proactively shape Guardant’s corporate development strategy to help by identifying industry trends, maintaining relationships with relevant external partners, as well as sourcing, negotiating, structuring, and executing strategic acquisitions/investments across all of the Company’s geographies and businesses.Essential Duties and Responsibilities:Lead the transaction due diligence processDevelop business cases supported by market, valuation and financial analyticsSupport the Company’s growth strategy through identification, assessment and execution of potential M&A, investments and partnerships.Support a robust and comprehensive process to identify and evaluate potential opportunities, which includes a rigorous idea generation and screening process that will bring quality acquisition and investment ideas to the Company’s executive management teamCollaborate with leaders to think about corporate development opportunities in a progressive, systematic and routine fashion.Partner with business leaders before, during and after the M&A processes to ensure the deals make strategic sense, fit with forward-looking business plans, and are integrated smoothly and fully optimizedSupport cross-functional teams in developing acquisition business case analyses and executing and interfacing with Finance, Accounting, Legal, Tax, HR and other departments of the Company to ensure seamless due diligence and deal executionEssential Qualifications:10+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank.Undergraduate business degree, MBA or PhD degree with a technical background in genomics, therapeutics, or oncology preferredM&A partnering and equity investment experience, including some negotiation, thorough execution, and transaction closingIntermediate or advanced understanding of the biotech, diagnostic, or medical device industrySuperior analytical and problem-solving skillsAbility to structure and manage complex projects and processes with multiple stakeholders at all levels, including Executive and senior levelsExcellent presentation skills, including strong oral and writing capabilities and the ability to clearly communicate compelling messages to the Executive teamAbility to travel, both domestically and internationally, 10% - 20% to conferences and meetingsHybrid Work Model
: At Guardant Health, we have defined days for in-person/onsite collaboration and work-from-home days for individual-focused time.For positions based in Palo Alto, CA or Redwood City, CA, the base salary range for this full-time position is $172,400 to $232,700. The range does not include benefits, and if applicable, bonus, commission, or equity.Guardant Health is committed to providing reasonable accommodations in our hiring processes for candidates with disabilities, long-term conditions, mental health conditions, or sincerely held religious beliefs.Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
#J-18808-Ljbffr
Full-timeGuardant Health is the leading precision oncology company with a dedication to conquering cancer globally. The Company was the first to develop proprietary genomics tests utilizing vast data sets and advanced analytics to find and characterize the basis of cancer in each patient individually. The Company operates through two unique platforms: Oncology and Screening.About the RoleThe Corporate Development Director is responsible for supporting the Corporate Development function for Guardant Health. The role will be integral in all group functional capacities and requires a self-starter familiar with the capital markets, strategy, valuation, and financial analysis. An ability to understand the basics of genomics is helpful to succeed. The candidate will help proactively shape Guardant’s corporate development strategy to help by identifying industry trends, maintaining relationships with relevant external partners, as well as sourcing, negotiating, structuring, and executing strategic acquisitions/investments across all of the Company’s geographies and businesses.Essential Duties and Responsibilities:Lead the transaction due diligence processDevelop business cases supported by market, valuation and financial analyticsSupport the Company’s growth strategy through identification, assessment and execution of potential M&A, investments and partnerships.Support a robust and comprehensive process to identify and evaluate potential opportunities, which includes a rigorous idea generation and screening process that will bring quality acquisition and investment ideas to the Company’s executive management teamCollaborate with leaders to think about corporate development opportunities in a progressive, systematic and routine fashion.Partner with business leaders before, during and after the M&A processes to ensure the deals make strategic sense, fit with forward-looking business plans, and are integrated smoothly and fully optimizedSupport cross-functional teams in developing acquisition business case analyses and executing and interfacing with Finance, Accounting, Legal, Tax, HR and other departments of the Company to ensure seamless due diligence and deal executionEssential Qualifications:10+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank.Undergraduate business degree, MBA or PhD degree with a technical background in genomics, therapeutics, or oncology preferredM&A partnering and equity investment experience, including some negotiation, thorough execution, and transaction closingIntermediate or advanced understanding of the biotech, diagnostic, or medical device industrySuperior analytical and problem-solving skillsAbility to structure and manage complex projects and processes with multiple stakeholders at all levels, including Executive and senior levelsExcellent presentation skills, including strong oral and writing capabilities and the ability to clearly communicate compelling messages to the Executive teamAbility to travel, both domestically and internationally, 10% - 20% to conferences and meetingsHybrid Work Model
: At Guardant Health, we have defined days for in-person/onsite collaboration and work-from-home days for individual-focused time.For positions based in Palo Alto, CA or Redwood City, CA, the base salary range for this full-time position is $172,400 to $232,700. The range does not include benefits, and if applicable, bonus, commission, or equity.Guardant Health is committed to providing reasonable accommodations in our hiring processes for candidates with disabilities, long-term conditions, mental health conditions, or sincerely held religious beliefs.Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
#J-18808-Ljbffr